Research on BAFF blockade therapy for childhood LN remains limited; however, multiple randomized trials of nonrenal SLE have shown that the efficacy and safety of belimumab are comparable in pediatric and adult patients [22, 23]. The gene discussed is TNFSF13B; the disease is systemic lupus erythematosus.